Following the chemical industry news from the world

Provided by AGP

Got News to Share?

Joe Binley launches Mastering Metabolism on protein signaling and performance

May 5, 2026
Joe Binley launches Mastering Metabolism on protein signaling and performance

By AI, Created 11:07 AM UTC, May 20, 2026, /AGP/ – Joe Binley, founder of Project AD and a corporate partner of Genesis Regenerative, has launched Mastering Metabolism, a new book framing protein signaling as a missing layer in performance and recovery. The release argues that aligning metabolism, biochemistry and gene expression could change how high performers approach longevity and physiological repair.

Why it matters: - The book pushes a “total human” model of restoration that combines nutrition, supplementation and non-cellular technology. - Binley’s framework could influence how elite athletes, executives and other high performers think about recovery, metabolic resilience and longevity. - Genesis Regenerative’s RPA is positioned as a foundational layer rather than a standalone add-on, which is the core shift in the release.

What happened: - Joe Binley announced the launch of Mastering Metabolism (2026). - Binley is the founder of Project AD and the architect of Sanctum, a performance community for athletes, executives and other high performers. - The book presents a systems-level framework for protein cycling and metabolic flexibility. - The release says the framework formally integrates non-cellular protein signaling into physiological repair. - Binley is a corporate partner of Genesis Regenerative.

The details: - The book argues that peak performance requires synchronization across three biological levels: metabolism, biochemistry and gene expression. - Binley says diet addresses metabolism, supplements address biochemistry and regenerative medicine addresses gene expression. - Genesis Regenerative’s Regenerative Protein Array, or RPA, contains more than 300 signaling proteins, growth factors and cytokines. - The release says the RPA helps influence the body’s internal signaling environment to support recovery and longevity. - Binley says the framework he had built over more than a decade felt incomplete until he began using the RPA. - The release describes Sanctum as a place where Binley has spent more than a decade helping high performers rebuild their physiological foundations. - Genesis Regenerative is described as a leader in non-cellular products that develops and markets the RPA. - The company says it aims to set a new standard of care through ethical practices, educational resources and support for patients and clinicians. - The book is also described as a systems-level framework on protein cycling, metabolic flexibility and longevity. - More information is available in the company’s announcement and the book page.

Between the lines: - The release is less about a single product than a broader attempt to redefine performance optimization around signaling biology. - By placing protein signaling underneath diet and supplementation, Binley is arguing that traditional wellness tools may be incomplete on their own. - The messaging also suggests Genesis wants to move beyond niche regenerative language and into mainstream performance and longevity conversations.

What’s next: - The Sanctum community will continue using Genesis Regenerative technology as part of its restoration model. - Binley’s framework will likely be tested by how well it resonates with athletes, executives and clinicians looking for new recovery strategies. - Genesis Regenerative appears set to keep promoting the RPA as part of its broader education and care model.

The bottom line: - Binley is betting that protein signaling, not just nutrition, will become a central lens for performance, recovery and longevity.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Chemicals Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share us

on your social networks:

Sign up for:

Chemicals Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.